Advice You - Business

Procurement describes the acquisition of goods or services at the best possible cost, in the right quantity,

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

time and place, for the direct benefit of the firm. The question now arises: how do you prioritize when you

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

only have a limited amount of money to spend? That’s where the role of budgeting comes in.

A budget is a qu

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ntitative expression of financial plans. How are budgets useful? Budgets induce management to think systemat

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

cally about the future. They also serve as a device for coordinating the complex operations of the business,

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

and provide a medium for communicating the financial goals of the firm.

In order to be useful, the budget m

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

st be drawn up for a specific time period. Usually, the budget is drawn up for a year. The operating budget

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

for the firm may be constructed in terms of programs or responsibility areas. The program budget is develope

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

in terms of products that are regarded as the principal programs of the business. Such a budget shows the e

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

pected costs and benefits of various products and services.

A cost center is responsible for keeping track

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

f costs and expenses. To assess its performance, the actual costs are compared with the budgeted costs. The

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

atter represent expenses that should have been incurred, given the actual activity level. The variance betwe

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

n actual costs and budgeted costs is analyzed for control purposes.

What is the base for preparing the budg

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

t? A commonly used base is the level of operations in the current year. Using this, the expected and planned

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

changes in the forthcoming year are identified to develop the budget for that year. Under this approach, re

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

erred to as the incremental approach to budgeting, the focus of budgeting is on the operations during the bu

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

get period.

In every firm, there is a critical factor which sets a limit to its level of activity. Often, t

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

e expected demand is the limiting factor that defines the scope and level of operations. When the demand is

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

airly strong, the limiting factor may be the production capacity of the firm, which cannot be augmented in t

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e short run. For firms that do not have easy access to the capital market, finances may be a limiting factor

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/3386/adviceyou-Procurement-Budgeting.html">Procurement Budgeting</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/3386/adviceyou-Procurement-Budgeting.html]Procurement Budgeting[/url]

Money making message boards can offer unique ways to make money that actually work, but it is important to make sure that those who are giving advice know what they are talking about.

Material handling or bulk material handling is a branch of engineering that deals in designing equipments for transporting materials in large quantities in a planned and effective way.

Tags

Links

Advice You - Procurement Budgeting

Related Articles: